Shavari
Shavari Granola Bars for breastfeeding
Mothers’ milk remains the most important source of nutrition for babies in their first six months. It is said that the first colostrum is the most essential food that a newborn should have. Nothing can replace a mother’s milk and it is extremely important for shaping the mother-baby bond as well. This is exactly the reason why The World Health Organization (WHO) recommends a mother’s milk for at least the first six months.
However, owing to several health conditions, some mothers may be unable to provide sufficient milk to their babies. A few factors responsible are:
Hormonal changes
Nutritional deficiencies
Improper lactating positions
Insufficient secretions
Can these Issues be Treated?
Medicines containing the queen of herbs Shatavari are widely advocated for addressing lactational problems. Shatavari, for one, remains a good galactagogue. The roots of Shatavari contain phytoestrogen, which regulates the presence of estrogen in skin and ovaries.
Estrogen, on the other hand, is largely responsible for the growth of the prolactin-producing cells. Shatavari plays the role of efficient lactation support by accelerating the production of corticoids and prolactin that append to the quality of breast milk offered by lactating moms.
How Can Shavari from ACT Help?
Our Shatavari-rich product, Shavari is our endeavor to bring to you the efficacy of the herb without compromising on its taste. Shatavari, since, it tastes bitter is available in the form of capsules and granules. Granules with up to 80% of added sugar negate most of the health benefits of the herb. Capsules, on the other hand, have compliance issues to contend with. This is the reason why our mentor Dr. Amita Birla presents to you, the best lactation bars, complete with a taste and health benefits.
Reach out to ACT to place your order for premium lactation bars to keep breastfeeding issues at bay.
FAQ
Can Shavari - Lactation Granola Bars increase breast milk?
Shatavari is a well-known galactagogue. Prolactin helps in milk secretion. Shatavari stimulates prolactin production directly, as well as suppressing dopamine. It improves the quality and the amount of breast milk produced by a lactating mother. Shatavari also stimulates the secretion of steroid hormones that improve milk production and also increases breast weight. Shatavari is thus very beneficial.
Is Shatavari granola bars safe for breastfeeding?
Yes, Granola Bars are safe for breastfeeding.
Can I eat granola while breastfeeding?
Yes, its best way of taking oats, Shatavari, almonds, and raisins which are beneficial and nutritional. With the richness of multiple vitamins and micronutrients along with Shatavari, this granola bar can support you during the lactation period. Moreover, there is no need to take sweetened Shatavari granules/powder with milk/water or take capsules multiple times.
Do lactation granola bars really work?
Lactation bars can support the lactation phase. Not only increases milk supply but also takes care of the postpartum depression, great antioxidant and anti-inflammatory support and also regularises the menstrual cycle.
Clinical Trail
Only researched Lactation Bar in India:
Aim of the Study:
To assess the efficacy and safety of a Shavari Bar® on increasing the breast milk output in post-partum women.
Objectives:
Evaluate the efficacy of a formulation Shavari Bar® vs. control/ Placebo on increasing the breast milk output in post-partum women
Evaluate the safety of a formulation Shavari Bar® vs. control/Placebo on increasing the breast milk output in post-partum women
Study setting:
Dept. of Obstetrics & Gynecology, D Y Patil Hospital, Nerul, Navi Mumbai 400 706, Maharashtra, India
N M Medical Center
Methods: A prospective, randomized, parallel-group, double-blind, placebo-controlled study was conducted at 2 centers in women with gestational age 37 weeks or more who intended to breastfeed. An EC approval was obtained. The patients were randomized in two groups: Group A: Placebo and Group B: Shavari Bar®. Observations were noted on day 3-4 and Day 5-7. Parameters observed were time to noticeable breast fullness and milk volume measurements. Milk volume was measured after the expression of breast milk from both breasts using a standard breast pump. Milk volume was measured 72 hours after delivery or after the patient had at least consumed 4 bars whichever was later.
Results: Hundred and four patients were assessed for the study, 78 patients were randomized and completed the study. Of the 78 patients, 61 had undergone a lower (uterine) segment Caesarean section (LSCS) and 17 had a normal delivery. Demography and baseline data of patients enrolled were similar in both groups. There was a statistical difference in total milk volume between the two groups (p< 0.008). The time to breast fullness was 38.09 hrs and 30.49 hrs respectively in the placebo Vs treatment arm and milk volume was 49.69 ml and 64.74 ml respectively in the placebo Vs treatment arm. In the LSCS group, time to breast fullness was 40.65 hrs and 32.2 hrs (p 0.032) and similarly, the milk volume was 52.35 ml and 66.67 ml (p 0.029) respectively in the placebo vs. treatment groups.
In the FTND group time to breast fullness was 28.19 hrs and 24.78 hrs (p 0.475) and milk volume was 39.38 ml and 58.33 ml (p 0.084) respectively in the placebo vs treatment groups.
No adverse events were noted in either of the groups. Global assessment of the Satisfaction of mothers for lactation, the well-being of the child, taste and ease of use was better in the treatment arm than in the placebo arm.
Time to breast fullness and milk volume extracted after 72 hrs.
| Placebo | Shavari | t-test | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | Mean | SD | N | Mean | SD | ‘p’ | ||||
| LSCS delivery (n=61) | ||||||||||
| Time to breast fullness | 31 | 40.65 | 17.08 | 30 | 32.20 | 12.55 | 0.032 | |||
| Total milk volume (ml) | 31 | 52.35 | 24.72 | 30 | 66.67 | 25.20 | 0.029 | |||
| FTND (n=17) | ||||||||||
| Time to breast fullness | 8 | 28.19 | 11.08 | 9 | 24.78 | 8.06 | 0.475 | |||
| Total milk volume (ml) | 8 | 39.38 | 27.44 | 9 | 58.33 | 13.23 | 0.084 | |||
| All patients (n=78) | ||||||||||
| Time to breast fullness | 39 | 38.09 | 16.70 | 39 | 30.49 | 12.00 | 0.024 | |||
| Total milk volume (ml) | 39 | 49.69 | 25.48 | 39 | 64.74 | 23.11 | 0.008 | |||
by